We break down the science behind peptides — what they actually do, which ones have real clinical evidence, and how to evaluate sourcing quality. Written for clinicians, pharmacists, and anyone doing serious research.
PeptideBond.com is for educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before starting any peptide protocol. Full disclaimer →
Three paths, depending on what you need.
Answer 6 quick questions about your goals and we'll match you to peptides that fit — with evidence ratings and cost ranges.
Compare 2 or 3 peptides side by side — mechanism, dosing, evidence level, regulatory status, and cost.
Browse all 80+ peptides with filters by category, evidence tier, and regulatory status. Every peptide links to a full reference entry.
Dr. William A. Seeds' Cellular Medicine framework — the clinical foundation behind modern peptide therapy practice.
Cellular Medicine treats the cell — not the organ — as the fundamental unit of disease. Published in Peptide Protocols: Volume One (2020), Dr. Seeds' framework organizes therapy around 11 pillar compounds addressing mitochondrial function, autophagy, tissue repair, and immune regulation. It is the protocol used by the International Peptide Society and the SSRP Institute.
The FDA has opened public comment on BPC-157, TB-500, and five other peptides. What compounding pharmacies and clinicians need to know.
Head-to-head on efficacy, mechanism, side effects, cost, and who each drug fits best. What the clinical trials actually show.
Separating signal from hype. Mechanism, what the animal data shows, the human evidence gap, and the regulatory story.
40 peptide entries · 155+ practice questions · AI-powered tools · Evidence-based
How to evaluate GMP manufacturers, read Certificates of Analysis, and source pharmaceutical-grade peptide APIs.
Explore Sourcing →Interactive tools that no other peptide education site offers. Build, analyze, study, and practice — all in one place.
Deep-dive monographs on the most clinically relevant peptides — mechanism, evidence, dosing, and sourcing.
Once a month, we send a plain-language digest of the most important new peptide research, regulatory changes, and sourcing red flags. Written for providers, pharmacists, and researchers who don't have time to read 30 papers a month. No ads. No affiliate links. Just the science.
A peptide is a short chain of amino acids — usually between 2 and 50 — connected by peptide bonds. They're smaller than proteins but play outsized roles in the body as signaling molecules, hormones, and regulators of everything from immune function to tissue repair. You've probably heard of a few already: collagen peptides, BPC-157, GHK-Cu, and insulin are all peptides.
It's the chemical bond that holds amino acids together. Specifically, the carboxyl group (-COOH) on one amino acid links to the amino group (-NH2) on the next, releasing a water molecule in the process. This dehydration reaction is how all peptides and proteins get assembled — one bond at a time. Understanding peptide bond chemistry is foundational to understanding how peptides work in the body.
Collagen peptides (sometimes labeled "hydrolyzed collagen") are collagen protein that's been broken into small, water-soluble fragments through enzymatic processing. They absorb well — roughly 90% gut absorption — and the interesting part is they don't just supply amino acids. Clinical research shows these peptide fragments signal your body's fibroblasts to produce new collagen in skin, joints, bones, and gut lining. The best-studied benefits are skin elasticity, joint pain reduction, and bone density support.
It depends entirely on which peptide you're talking about. Collagen peptides have GRAS status from the FDA — they're widely considered safe at standard doses. Research peptides like BPC-157 and TB-500 have promising safety profiles in animal studies and some preliminary human data, but most are not FDA-approved for therapeutic use in humans. The regulatory landscape has been shifting rapidly — the FDA restricted compounding of 19 peptides in late 2023, then HHS announced in February 2026 that most would be reclassified back to Category 1 (eligible for compounding). Bottom line: always work with a licensed provider who understands the current regulatory status of whatever peptide you're considering.
Size, mainly. Peptides are short chains — typically 2 to 50 amino acids — while proteins are longer (50+ amino acids) and fold into complex 3D structures. Functionally, peptides tend to act as signaling molecules and hormones, while proteins handle structural jobs (like collagen and keratin) and catalytic ones (enzymes). The dividing line between a large peptide and a small protein is honestly somewhat arbitrary — insulin, for example, sits right on the boundary at 51 amino acids.
The information on PeptideBond.com is provided for educational and informational purposes only. Nothing on this website constitutes medical advice, diagnosis, or treatment. The content is not intended to be a substitute for professional medical advice from a licensed healthcare provider. Never disregard professional medical advice or delay seeking treatment because of something you have read on this website.
Use of this website does not create a provider-patient relationship between you and PeptideBond.com or any affiliated entities. PeptideBond.com does not prescribe medications, diagnose conditions, or provide individualized treatment recommendations. Referrals to partner telehealth providers are for informational convenience only — all clinical decisions are made exclusively by the treating provider.
Many peptides listed in this directory are not FDA-approved for human therapeutic use. Compounded peptides are prepared by state-licensed pharmacies under Section 503A or 503B of the FD&C Act. Investigational compounds are available only through clinical trials. Research-use-only (RUO) compounds are not intended for human administration. Regulatory status varies by jurisdiction — verify local regulations before use.
The Research AI feature uses artificial intelligence (Claude by Anthropic) with web search to find published literature and assist with clinical reasoning. AI can occasionally misattribute citations, present incomplete evidence, or generate inaccurate information. All AI-generated responses must be independently verified by the provider through PubMed, Google Scholar, ClinicalTrials.gov, or other authoritative sources before clinical application.
Dosing protocols, clinical data, and evidence ratings are sourced from: FDA-approved drugs — official prescribing information; Compounded peptides — commonly cited clinical usage (not standardized FDA dosing); Investigational drugs — published Phase II/III trial protocols; Research-only compounds — preclinical/animal data. IV drip formulations vary by clinic. Data is reviewed periodically but may not reflect the most recent updates. Report errors to [email protected].
PeptideBond is reader-supported through optional newsletter subscriptions. We do not accept advertising, affiliate commissions, supplier sponsorships, or referral fees. Editorial decisions are made independently of any commercial relationship.